(−)-Epigallocatechin-3-gallate (EGCG) ameliorates ovalbumin-induced asthma by inhibiting inflammation via the TNF-α/TNF-R1/NLRP3 signaling pathway

Beibei Zhang(First Affiliated Hospital of Henan University), Weisheng Feng(First Affiliated Hospital of Henan University), Yuanyuan Wu(First Affiliated Hospital of Henan University), Mengnan Zeng(First Affiliated Hospital of Henan University), Qi-Mei Tie(First Affiliated Hospital of Henan University), Ru Wang(Harbin Institute of Technology), Mengya Wang(First Affiliated Hospital of Henan University)
International Immunopharmacology
December 3, 2024
Cited by 17


Related Papers